News | Alzheimer's Prevention Registry

You are here


Come back regularly for the latest news and information about Alzheimer’s disease and prevention.

October 16, 2017
by Alzheimer's Prevention Bulletin
October is heralded by a parade of pink – with a near-constant focus on breast cancer. And deservedly so, since statistics show that 12 percent of women may develop the disease. But did you know that...
September 21, 2017
by The Economic Times
More than four million people in India are afflicted with some form of dementia, with Alzheimer's being the most common cause. 
A simple Google search about Alzheimer’s prevention turns up countless prospective remedies — and few answers.
The impact of Alzheimer's is felt around the country. According to the Alzheimer's Association, more than 5 million Americans live with the disease and it is the sixth leading cause of death in the...
Glen Campbell, the multiple Grammy-winning country-pop singer, guitarist and TV personality whose half-century career was capped by a singular last act after he went public with his advancing...
June 1, 2017
by BAI Beacon - Family and Community Services
Scientists are still trying to determine the underlying causes of Alzheimer’s disease. The hope is that one day we will be able to stop the disease from progressing or perhaps even...
March 27, 2017
by Alzheimer's Prevention Bulletin
This month’s expert is Beth McCarty Wood, MS, LCGC, Senior Genetic Counselor, Telegenetics Program at the University of Pennsylvania.   Dear Ms. McCarty Wood,   I submitted my DNA to the...
March 23, 2017
by Alzheimer's Prevention Registry
We're thrilled to announce a new partnership that will bring our resources in front of The Mighty's wide-reaching readership. We will now have a new and growing home on The Mighty and appear on many...
Scientists are hoping that a single drug can treat two devastating brain diseases: Parkinson's and Alzheimer's. The drug is nilotinib, which is approved to treat a form of leukemia.
The cost of providing care for Americans with Alzheimer’s disease has hit $259 billion–more than a quarter of a trillion dollars–as costs mount to treat more aging baby boomers entering long-term...